Related content

Agalsidase alfa: enzyme therapy for Anderson––Fabry disease

By Pastores G M  

Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. : 203-211

Future Medicine

Access to resources Recommend Favorite

Thrombocytosis Associated with Enzyme Replacement Therapy in Gaucher Disease

By  

Acta Haematologica, Vol. 108, Iss. 2, 2002-08 ,pp. : 94-96

Karger

Access to resources Recommend Favorite

Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients

By vom Dahl Stephan   Poll Ludger   Di Rocco Maja   Ciana Giovanni   Denes Carmencita   Mariani Giuliano   Maas Mario  

Current Medical Research and Opinion, Vol. 22, Iss. 6, 2006-06 ,pp. : 1045-1064

Informa Healthcare

Access to resources Recommend Favorite

Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease

By Matzner Ulrich   Matthes Frank   Weigelt Cecilia   Andersson Claes   Eistrup Carl   Fogh Jens   Gieselmann Volkmar  

Journal of Molecular Medicine, Vol. 86, Iss. 4, 2008-04 ,pp. : 433-442

Springer Publishing Company

Access to resources Recommend Favorite

Community-acquired Staphylococcus epidermidis Endocarditis Complicated by Splenic Disease 9 Years after Aortic Valve Replacement

By Melzer Mark   Maiden Hanna   Gransden William   Edgeworth Jonathon   Chan Yun   Kinirons Mark  

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 6, 1999-12 ,pp. : 595-596

Informa Healthcare

Access to resources Recommend Favorite